Evidence map›Paper›PMID 29177610›Full record

ArticleInfection2018

Findings from an outbreak of carbapenem-resistant Klebsiella pneumoniae emphasize the role of antibiotic treatment for cross transmission.

Stefan Borgmann, Yvonne Pfeifer, Laura Becker, Beate Rieß, Rabea Siegmund, Ulrich Sagel

Abstract read
PubMed Publisher
In one paragraph

Article in Infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Epidemiological and Clinical Features ofPathogens (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Prophylaxis and Treatment againstInternational journal of molecular sciences · 2021
    Review
  5. Long-Lasting Decrease of the Acquisition ofInternational journal of environmental research and public health · 2020
    Article
  6. The Global Ascendency of OXA-48-Type Carbapenemases.Clinical microbiology reviews · 2019
    Review
  7. Treatment withTherapeutics and clinical risk management · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Stefan BorgmannDepartment of Infectious Diseases and Infection Control, Klinikum Ingolstadt, Krumenauerstr. 25, 85049, Ingolstadt, Germany. stefan.borgmann@klinikum-ingolstadt.de.
Yvonne PfeiferNosocomial Pathogens and Antibiotic Resistance, Robert Koch Institute, Wernigerode, Germany.
Laura BeckerNosocomial Pathogens and Antibiotic Resistance, Robert Koch Institute, Wernigerode, Germany.
Beate RießDepartment of Infectious Diseases and Infection Control, Klinikum Ingolstadt, Krumenauerstr. 25, 85049, Ingolstadt, Germany.
Rabea SiegmundDepartment of Infectious Diseases and Infection Control, Klinikum Ingolstadt, Krumenauerstr. 25, 85049, Ingolstadt, Germany.
Ulrich SagelClinical Institute of Hygiene and Microbiology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria.
Klinikum Ingolstadt · DERobert Koch Institute · DEUniversitätsklinikum St. Pölten · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn January 2015, we noticed by rectal swab analyses that seven of 23 patients at an early rehabilitation ward had been colonized with carbapenem-resistant Klebsiella pneumoniae (CKP). Here, we describe risk factors for CKP acquisition.

methodsIn the present study, the outbreak is described and risk factors for CKP acquisition are examined, e.g., antibiotic treatment. Microbiological analyses including corresponding results were examined to study when colonization with CKP occurred and whether patients had suffered from diarrhea. To examine whether spread of bacteria was clonal, multi-locus sequence typing as well as Xbal macrorestriction and pulsed-field gel electrophoresis was performed. The presence of carbapenmase was examined by PCR analysis. Through univariate analysis of risk factors in the small study sample, the role of antibiotic consumption, isolation procedures, patient's age, gender, and Barthel index on colonization was elucidated.

resultsClonal spread of the novel sequence type (ST)2255 was identified. Additionally, one patient was colonized with Escherichia coli and Serratia marcescens, both resistant to carbapenems, while a further patient carried another carbapenem-resistant E. coli strain. In all isolates, carbapenemase gene bla

conclusionsIn this small outbreak, antibiotic treatment seemed to be the predominant risk factor for monoclonal transmission of bla

Indexed as

Disease OutbreaksDrug Resistance, BacterialAdultAgedAged, 80 and overbeta-LactamasesCarbapenemsCross InfectionFemaleGermanyHumansKlebsiella InfectionsKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsMiddle Agedbeta-LactamasesCarbapenemsoxacillinaseConjugative transferCTX-M-15Escherichia coliOXA-48Serratia marcescens

Identifiers

PMID29177610
OpenAlexW2768893084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.